Skip to content

Abbott

Recent events

Recent events tied to this brand in public sources.

Back to profile63 entries · Page 2 of 4

  1. 2022

    Abbott recalls certain ready-to-feed formula products over bottle-cap sealing defect

    Abbott announced a recall of some ready-to-feed liquid formula products for infants and children, including Similac and Pedialyte Electrolyte Solution. Abbott said caps on a small percentage of bottles in the recalled lots may not have sealed completely, which could result in spoilage and gastrointestinal symptoms if consumed.

  2. 2022

    FDA approves Abbott's Proclaim Plus spinal cord stimulation system

    Abbott announced that the U.S. Food and Drug Administration approved its Proclaim Plus spinal cord stimulation system featuring FlexBurst360 therapy.

  3. 2022

    Lawsuit alleges Abbott formula caused premature infant's death

    Brianna Anthony filed a lawsuit against Abbott Laboratories alleging that Similac caused her premature infant's death and that the product was dangerous to premature babies. These are allegations in the lawsuit, not stated court findings. Abbott said the allegations were without merit.

  4. 2022

    Abbott reports second-quarter earnings

    Abbott reported strong earnings on July 20, 2022. Adjusted earnings per share grew 22% to $1.43, and sales rose 14% to $11.3 billion.

  5. 2022

    Shoppers Drug Mart recalls certain Abbott infant formula products

    Shoppers Drug Mart locations recalled certain Abbott brand powdered infant formula products due to potential Cronobacter sakazakii and Salmonella contamination.

  6. 2022

    Abbott apologizes for US baby formula shortage

    Abbott CEO Robert Ford apologized to US families affected by the baby formula shortage. The article says Abbott's voluntary recall had exacerbated the shortage.

  7. 2022

    Abbott completes India baby formula recall

    Abbott's India unit completed a voluntary recall in India affecting Alimentum and EleCare baby formula products manufactured at Abbott's Michigan facility. The report links the facility's shutdown to reports of bacterial infections in infants who consumed products made there.

  8. 2022

    Government report describes possible Abbott formula contamination

    A news report citing a latest government document said investigators found that infant formula made at Abbott's Michigan facility may have been contaminated months before the recall. The article also reports that investigators said contaminants, including Cronobacter, could potentially have been transferred to formula; it does not establish that the potentially affected batch was distributed.

  9. 2022

    Abbott home COVID-19 antigen test kit sale announced

    Taiwan's Ministry of Economic Affairs said Abbott's home COVID-19 antigen rapid test kit would go on sale the following day, through Watsons, four convenience-store chains, PX Mart and Simple Mart.

  10. 2022

    Parent sues Abbott over alleged infant formula injuries

    A parent filed a complaint against Abbott Laboratories alleging that Abbott cow’s-milk-based formula and/or fortifier caused a premature infant to develop NEC and that the products were misleadingly marketed and inadequately warned about potential risks. These are allegations in the complaint, not a court determination.

  11. 2022

    Abbott recalls a lot of Similac PM 60/40 formula

    Abbott Laboratories issued a second round of baby formula recalls on February 28, 2022, covering one lot of Similac PM 60/40. The article says the recall followed the company learning that an infant who consumed the formula had died after contracting a Cronobacter sakazakii infection; it does not establish that the formula caused the death.

  12. 2022

    Abbott recalls six lots of Similac Alimentum in Vietnam

    Abbott Laboratories GmbH’s Hanoi representative office announced a voluntary recall in Vietnam of six lots of Similac Alimentum Eye-Q powdered infant formula because they potentially contained two kinds of dangerous bacteria. The article reports that 7,050 cartons had entered the market and that the importer notified customers about the recall.

  13. 2022

    Abbott recalls three infant formula products

    Abbott recalled three infant formula products after Cronobacter sakazakii was found in a non-product-contact area of a Michigan factory; the source says the products could pose a health risk to infants aged 0–6 months and that the investigation was ongoing.

  14. 2022

    Vietnam orders recall of certain Abbott formula products

    Vietnam's Food Safety Authority issued a recall of certain potentially contaminated food products sold by Abbott after reports of contamination incidents in the U.S. The agency contacted importers and asked them to recall the products.

  15. 2022

    Abbott recalls potentially affected powdered infant formulas

    Abbott said it was recalling potentially affected products manufactured at its Sturgis, Michigan facility after reports of infant illnesses linked to bacterial contamination. The recall affected certain products with expiration dates of April 1, 2022, or later. Abbott expressed regret for the concern and inconvenience the situation would cause.

  16. 2022

    Abbott announces recall of three infant-formula product lines

    Abbott announced a voluntary recall of Similac, Alimentum and EleCare formula produced at its Sturgis, Michigan factory. The article identifies affected product codes and expiration dates.

  17. 2021

    Lawsuit filed against formula manufacturers over alleged NEC-related injuries

    A plaintiff filed suit against Abbott Laboratories, Inc., Mead Johnson & Company, LLC, and Mead Johnson Nutrition Company, alleging that their cow’s-milk-based products caused an infant’s injuries and asserting failure-to-warn, defective-product, and negligence claims. These are allegations in the complaint.

  18. 2021

    Lawsuit filed against Abbott over infant formula

    A parent filed a product-liability lawsuit against Abbott Laboratories concerning cow’s milk-based infant formula fed to a premature baby. The plaintiff alleges that the product was falsely marketed as being as safe as breast milk and asserts claims including design defect, failure to warn, and negligence.

  19. 2021

    FDA approves Abbott Portico with FlexNav TAVR system

    The US Food and Drug Administration approved Abbott's Portico with FlexNav transcatheter aortic valve replacement system for certain patients with severe aortic stenosis who are at high or extreme risk for open-heart surgery.

  20. 2021

    Abbott's Shanghai entity fined over advertising violations

    The Shanghai Municipal Administration for Market Regulation fined Abbott Trading (Shanghai) Co., Ltd. RMB 848,000 and ordered it to stop publishing advertisements for medical services, medicines and medical devices that violated regulations.